These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10216129)

  • 1. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
    Radaeva S; Ferreira-Gonzalez A; Sirica AE
    Hepatology; 1999 May; 29(5):1453-62. PubMed ID: 10216129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver.
    Lai GH; Radaeva S; Nakamura T; Sirica AE
    Hepatology; 2000 Jun; 31(6):1257-65. PubMed ID: 10827151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
    Sirica AE; Radaeva S; Caran N
    Am J Pathol; 1997 Dec; 151(6):1685-94. PubMed ID: 9403719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.
    Elmore LW; Sirica AE
    Cancer Res; 1991 Oct; 51(20):5752-9. PubMed ID: 1655260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
    Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
    Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
    Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
    Lai GH; Zhang Z; Shen XN; Ward DJ; Dewitt JL; Holt SE; Rozich RA; Hixson DC; Sirica AE
    Gastroenterology; 2005 Dec; 129(6):2047-57. PubMed ID: 16344070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an intestine-specific transcription factor (CDX1) in intestinal metaplasia and in subsequently developed intestinal type of cholangiocarcinoma in rat liver.
    Ren P; Silberg DG; Sirica AE
    Am J Pathol; 2000 Feb; 156(2):621-7. PubMed ID: 10666391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
    Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
    Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Intestinal-type" of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan.
    Elmore LW; Sirica AE
    Cancer Res; 1993 Jan; 53(2):254-9. PubMed ID: 7678071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis.
    Sirica AE
    Toxicol Pathol; 1996; 24(1):90-9. PubMed ID: 8839286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
    Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
    Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan-treated rats.
    Elmore LW; Sirica AE
    Hepatology; 1992 Nov; 16(5):1220-6. PubMed ID: 1427660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma.
    Varnholt H; Asayama Y; Aishima S; Taguchi K; Sugimachi K; Tsuneyoshi M
    Oncol Rep; 2002; 9(1):35-41. PubMed ID: 11748452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
    Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
    Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N; Grenert JP; Sahai V; Kakar S
    Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.